KAMADA
@Kamada_Pharma
Followers
63
Following
11
Media
69
Statuses
88
Kamada is a global biopharmaceutical company with a portfolio of products indicated for rare and serious conditions and a leader in specialty-plasma therapies.
Israel, United States
Joined March 2017
Our long-term commitment to Alpha-1 means partnering with the community, driving awareness, supporting research, and delivering high-quality augmentation therapy.
0
0
1
Alpha-1 Antitrypsin Deficiency is still underdiagnosed. For patients with lung involvement, plasma-derived augmentation therapy can help slow progression. Learn more at: https://t.co/9lrgxucqE4
0
0
1
SHIELD is a new prospective study evaluating CYTOGAM to help prevent late CMV in high-risk kidney transplant recipients. This investigator-initiated trial is supported by @Kamada_Pharma. Learn more: https://t.co/vyNqvwKH7I
0
0
0
Still thinking it’s asthma or COPD? It could be Alpha-1! This Awareness Month, @Kamada_Pharma reinforces its commitment to expanding awareness and supporting patients worldwide.
0
0
0
This #PlasmaAwarenessWeek, @Kamada_Pharma joins the Plasma Protein Therapeutics Association (PPTA) in highlighting plasma donation and plasma-derived medicines.
0
0
0
Proud to join the ERS International Congress this week in Amsterdam, advancing lung disease care with clinicians, partners & advocates worldwide. #ERSCongress #LungHealth
0
1
1
On #WorldRabiesDay we remind: rabies kills thousands, but rapid post-exposure care saves lives. For over 20 years @Kamada_Pharma has helped deliver this vital protection worldwide.
0
1
2
People with ITP have low platelet count, leading to easy bruising, bleeding, and sometimes more serious internal bleeding. This ITP Awareness Week, we stand with the community to raise awareness and reinforce the importance of education and access to care.
0
0
0
👉 Check out CMV Stream 2025 by #Kamada, which is now available on-demand. Leading voices in #transplantation addressed the latest updates, key challenges, and evolving strategies in #CMV management and prevention.💡📽️ Watch now at 🔗: https://t.co/Dp3sXwrSY7
0
3
2
Our new plasma collection center in Houston has FDA approval and is ready for commercial sales. Read more: https://t.co/D3dKIpiqfd
0
0
0
Proud to have been part of World Transplant Congress 2025, where we connected with colleagues, learned the latest, and worked together to advance care for the transplant patient community.
0
0
0
60% of those on the U.S. transplant waitlist are from communities of color. During #MinorityDonorAwarenessMonth, we stand for equity and honor the donors offering second chances.
0
0
1
Every 30 seconds, someone dies from hepatitis. Yet every death is preventable. At @Kamada_Pharma, we support awareness and prevention efforts, especially around HBV.
0
0
0
Excited to exhibit at #WTC2025 in San Francisco! Meet us at Booth #430 to explore our hyperimmune solutions for transplant patients! See you there! 🔗 https://t.co/WZQik4w2Te
0
0
1
Happy 4th of July from @Kamada_Pharma ! Proud to support U.S. patients & providers with trusted therapies. Wishing our teams & friends a joyful Independence Day! 🎆🇺🇸
0
0
0
🎥 The CMV Stream 2025 recording is now available! Top transplant experts discuss key updates from the new CMV consensus guidelines. https://t.co/13ntEwbYiY
#Transplant #CMV #SOT
0
1
2
@Kamada_Pharma is proud to advance CMV care through 10 U.S. studies with leading transplant experts, part of our CYTOGAM® post-marketing research program. https://t.co/zWkx9KgjIp
kamada.com
Program Aimed at Generating Key Data in Support of the Benefits of CYTOGAM® in the Management of Cytomegalovirus (CMV) in Solid Organ Transplantation A Total of 10 Studies will be Conducted in...
0
0
0
CMV, often called the "Troll of Transplantation", affects up to 70% of solid organ recipients and can lead to rejection and complications. @Kamada_Pharma is committed to raising awareness and improving care.
0
0
2
Happy #PrideMonth! At @Kamada_Pharma , we celebrate inclusion, respect, and the freedom to be yourself—today and every day. 🏳️🌈Pride2025
0
0
0
Kamada is proud to stand with vulnerable patients this CMV Awareness Month—committed to raising awareness and helping prevent CMV-related complications.
0
0
2